Literature DB >> 8332567

Cross-cultural issues in the course and treatment of schizophrenia.

M Karno1, J H Jenkins.   

Abstract

In conclusion, we strongly share the belief recently expressed by Lefley that "the dialogue on clinical and social implications of research on expressed emotion may play a positive role" in the provision of care through a mental health service system that enlists, supports, and trains diverse intra and extra-familial caregivers in the many therapeutic tasks required for the care of the person and family afflicted with schizophrenia. We regard such a prescription as applicable in all social and cultural contexts.

Entities:  

Mesh:

Year:  1993        PMID: 8332567

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  6 in total

1.  Considering context, place and culture: the National Latino and Asian American Study.

Authors:  Margarita Alegria; David Takeuchi; Glorisa Canino; Naihua Duan; Patrick Shrout; Xiao-Li Meng; William Vega; Nolan Zane; Doryliz Vila; Meghan Woo; Mildred Vera; Peter Guarnaccia; Sergio Aguilar-Gaxiola; Stanley Sue; Javier Escobar; Keh-Ming Lin; Fong Gong
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

2.  Culturally Based Intervention Development: The Case of Latino Families Dealing With Schizophrenia.

Authors:  Concepción Barrio; Ann-Marie Yamada
Journal:  Res Soc Work Pract       Date:  2010-09-01

3.  Family Life and Social Medicine: Discourses and Discontents Surrounding Puebla's Psychiatric Care.

Authors:  Kathryn Law Hale
Journal:  Cult Med Psychiatry       Date:  2017-12

4.  The involvement of families in Indian psychiatry.

Authors:  M Nunley
Journal:  Cult Med Psychiatry       Date:  1998-09

5.  Psychiatric diagnosis - is it universal or relative to culture?

Authors:  Glorisa Canino; Margarita Alegría
Journal:  J Child Psychol Psychiatry       Date:  2008-03       Impact factor: 8.982

6.  The global prevalence of schizophrenia.

Authors:  Dinesh Bhugra
Journal:  PLoS Med       Date:  2005-05-31       Impact factor: 11.069

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.